Skip to main content

Table 2 Baseline lab characteristics of study population

From: Survival outcomes of patients with concomitant acute variceal bleeding and acute coronary syndrome, and the role of antiplatelet agents: an institutional experience from a lower middle-income Country

Baseline characteristics

Total (n = 29)

Survivor group (n = 22)

Non-survivor group (n = 7)

Significance (p-value)

Age

58.7 ± 11.0

58.6 ± 10.8

58.7 ± 12.5

0.987

At presentation

    

Systolic blood pressure (mmHg)

122.3 ± 28.9

127.3 ± 31.3

110.3 ± 18.8

0.196

Diastolic blood pressure (mmHg)

72.5 ± 18.5

75.1 ± 20.0

66.3 ± 13.4

0.301

Pulse/heart rate (/min)

112.5 ± 17.5

110.5 ± 19.4

117.1 ± 11.8

0.413

Hemoglobin (Hb) (g/dl)

7.97 ± 2.0

7.75 ± 2.2

8.66 ± 1.5

0.313

INR

1.54 ± 0.8

1.31 ± 0.3

2.26 ± 1.3

0.095

Prothrombin time seconds)

16.8 ± 8.3

14.1 ± 3.6

24.9 ± 13.3

0.077

Total bilirubin (mg/dl)

3.17 ± 5.5

3.15 ± 6.2

3.21 ± 2.6

0.980

Albumin (g/dl)

2.72 ± 0.5

2.84 ± 0.5

2.37 ± 0.4

0.045*

Creatinine (mg/dl)

1.34 ± 0.8

1.27 ± 0.7

1.57 ± 1.0

0.378

Troponin (µg/dl)

18.1 ± 22.0

16.7 ± 18.9

22.5 ± 32.0

0.694

Child–PUGH score

8.76 ± 2.4

8.09 ± 2.1

10.8 ± 1.77

0.005*

Meld score

15.4 ± 8.8

13.4 ± 8.1

21.9 ± 8.0

0.023*

Stay in hospital

    

Hb in ward (g/dl)

8.44 ± 2.3

8.22 ± 2.2

8.96 ± 2.7

0.493

Drop in Hb from baseline (g/dl)

1.53 ± 1.9

0.96 ± 1.6

2.91 ± 1.8

0.017*

  1. All numerical values as Mean ± S.D. Independent student t-test for numerical variables. *P-values are significant (< 0.05)